News
AYRWF
2.340
+1.74%
0.040
Cannabis MSOs get date for oral arguments in federal marijuana law case
Federal judge in Massachusetts sets May 22 as the date for oral arguments in federal marijuana law case. Cannabis MSOs argue MSOs should be shielded from federal marijuana prohibition laws in states where the plant is legal. The key issue in the case is whether the federal government can interfere in cannabis businesses in legal states.
Seeking Alpha · 1h ago
Cannabis stocks outperform as pressure mount on DEA to reschedule marijuana
Seeking Alpha · 1d ago
Weekly Report: what happened at AYRWF last week (0415-0419)?
Weekly Report · 4d ago
4/20 Cannabis Retail Frenzy: Leading Brands Ready For Record Sales Surge - Who Will Lead?
Benzinga · 6d ago
On eve of 4/20, White House and Democratic lawmaker tout marijuana progress
White House and Democratic lawmaker tout marijuana progress on eve of 4/20 Day. President Biden has promised to decriminalize marijuana on the federal level. The Justice Department is reviewing a recommendation to move marijuana from a Schedule I to a Schedule III drug. Rep. Earl Blumenauer says this is the last time cannabis will be on Schedule I.
Seeking Alpha · 6d ago
Marijuana groups call on Biden to remove cannabis from Controlled Substances Act
Seeking Alpha · 04/18 20:19
Marijuana banking could pass House in must-pass bill - report
Seeking Alpha · 04/18 18:17
Ron DeSantis Says People Will Be 'Toking Up' Near Schools If Cannabis Legalization Is Approved In November
Gov. Ron DeSantis took a swipe at the cannabis legalization amendment Floridians will vote on in the November 2024 elections. The proposal, known as Amendment 3, was approved by the Florida Supreme Court to advance to the November ballot. The governor went after the cannabis companies that support the initiative.
Benzinga · 04/17 23:20
Marijuana banking unlikely to pass House due to Republican leadership spat
Seeking Alpha · 04/17 19:34
White House says marijuana rescheduling review is now with DOJ
White House says marijuana rescheduling review is now with DOJ. The much-anticipated decision is expected to reclassify cannabis in a low-risk category called Schedule III. Currently, cannabis is included under Schedule I. DEA confirmed the ongoing review in February. White House says it's now up to the Department of Justice to decide.
Seeking Alpha · 04/16 14:13
Marijuana banking legislation could be attached to crypto bill - report
Healthcare Consumer Marijuana banking legislation could be attached to crypto bill - report. Senate Majority Leader Chuck Schumer brought up the prospect to the House Financial Services Committee in August. The Secure and Fair Enforcement Regulation Banking Act could be added to a bill aimed at cryptocurrency regulation. The SAFER Banking bill would bring about marijuana banking reform.
Seeking Alpha · 04/15 18:00
Weekly Report: what happened at AYRWF last week (0408-0412)?
Weekly Report · 04/15 11:42
Ayr Wellness files $250M mixed securities shelf
Seeking Alpha · 04/12 11:02
FDA chief sees no reason for delay in cannabis rescheduling
FDA chief sees no reason for delay in cannabis rescheduling. The DEA is reviewing whether to reschedule marijuana from a high-risk to a low-risk category. A favorable decision will see marijuana move to a Schedule III drug category from its current Schedule I status.
Seeking Alpha · 04/11 19:38
Cannabis Market's Trading Volume Surges Up 292%, Viridian Capital Highlights Mixed Liquidity
A recent analysis by Viridian Capital Advisors provides insights into the liquidity of cannabis companies. Average daily dollar trading volume has increased in the industry, but some companies are facing liquidity challenges. All 14 companies examined show a higher average daily trading volume in 2024 compared to 2023. The report highlights the need to focus on companies with better liquidity.
Benzinga · 04/11 17:17
AYR Wellness Inc. Announces Q1 Earnings Call
TipRanks · 04/11 12:08
AYR Wellness to Hold First Quarter 2024 Conference Call on May 15 at 8:30 a.m. ET
AYR Wellness Inc. Will hold a conference call on May 15, 2024, to discuss its results for the first quarter ended March 31, 2024. The company is a leading vertically integrated U.S. Multi-state cannabis operator. The conference call will be held in Miami, Florida.
Barchart · 04/11 06:30
Eclipsing Prohibition: US Cannabis Industry Report Shows Growth Amid Regulatory Anticipation
Jesse Redmond provides a comprehensive overview of the cannabis industry in his latest report from Water Tower Research. The cannabis industry witnessed notable fluctuations in the past week. Redmond highlights AYR Wellness as a front-runner for 2024. The Benzinga Cannabis Capital Conference will be held in Florida on April 16-17.
Benzinga · 04/09 19:32
Weekly Report: what happened at AYRWF last week (0401-0405)?
Weekly Report · 04/08 11:48
Cannabis rally sparks concerns amid moves to mainstream
Pot stocks have bounced back from recent lows as investors await favorable regulatory changes in the U.S. And global developments. The Florida Supreme Court ruled in favor of legalizing recreational marijuana in the state this week. A potential rescheduling decision from the DEA could be "imminent"
Seeking Alpha · 04/06 17:29
More
Webull provides a variety of real-time AYRWF stock news. You can receive the latest news about Ayr Wellness Inc. through multiple platforms. This information may help you make smarter investment decisions.
About AYRWF
Ayr Wellness Inc., formerly Ayr Strategies Inc., is a vertically integrated, United States (U.S) multi-state cannabis operator. The Company cultivates and manufactures branded cannabis products for distribution through its network of retail outlets and through third party stores. Its products include flower, concentrates, vapes, tinctures, topicals and edibles. Its flower product is a smokable part of the cannabis plant. Its concentrates are cannabis products that have been processed to remove extraneous components, leaving only the active compounds, primarily cannabinoids and terpenes. The vapes are devices that is pre-filled with extracted cannabis oils. The Company's tinctures are an alcohol or glycerol-based liquid cannabis extracts. Its topicals is a cannabis-infused product applied to the skin such as lotions, creams and balms. The Company’s edibles are food items made with cannabis flower or concentrates.